Bajaj Finance, Infosys, Angel One and 14 other companies to remain in focus as they trade ex-date tomorrow, May 30, 2025, following recent announcements of corporate actions, including dividends, bonus issues, and rights issues.

Bajaj Finance, Infosys, and Angel One are set to trade ex-date tomorrow, May 30, 2025, following announcements of corporate actions. Bajaj Finance has declared a ₹44 per share dividend, Angel One ₹26 per share, and Infosys ₹22 per share. Other companies have also announced dividends, bonuses, and rights issues, including Ujaas Energy, Bharat Bhushan Finance & Commodity Brokers, and GlaxoSmithKline Pharmaceuticals.

Equity market investors are keeping a close eye on shares of Bajaj Finance, Infosys, and Angel One, as these companies will trade ex-date tomorrow, May 30, 2025. This follows recent announcements of corporate actions, including dividends, bonus issues, and rights issues.

Bajaj Finance
Bajaj Finance has declared a final dividend of ₹44 per share [1]. This dividend will be paid to shareholders who own the shares before the ex-dividend date, which is May 30, 2025. Additionally, the company is expected to reissue over 2-year bonds, raising 30 billion rupees ($351.7 million) including a greenshoe option of 25 billion rupees [2].

Infosys
Infosys has announced a final dividend of ₹22 per share [3]. The dividend will be paid to shareholders who own the shares as of the record date, which is also May 30, 2025. The payment date for the dividend is June 30, 2025.

Angel One
Angel One has declared a final dividend of ₹26 per share [1]. This dividend will be paid to shareholders who own the shares before the ex-dividend date, which is May 30, 2025.

Other companies have also announced corporate actions. Ujaas Energy is expected to be in focus as it has announced a bonus issue in the ratio of 17:25 [1]. Bharat Bhushan Finance & Commodity Brokers has announced a rights issue involving 33,80,400 equity shares with a face value of ₹10 each, amounting to a total issue size of ₹3.38 crore [1]. GlaxoSmithKline Pharmaceuticals has declared a final dividend of ₹42 per share [1].

The ex-date refers to when a stock begins trading without the entitlement to dividends, rights issues, or bonus issues. This means that on or after this date, dividend, subdivision (stock split), bonus issue, or rights issue will not be available to a new buyer of the stock. To qualify for receiving these benefits, investors must own the stock before the ex-date. The beneficiaries of dividends, subdivisions (stock split), or rights issues, however, are determined by the company based on the list of investors recorded by the end of the record date.

References
[1] https://www.business-standard.com/markets/news/dividend-bonus-shares-rights-issue-bajaj-fin-infosys-14-more-in-focus-125052900135_1.html
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L3N3S006D:0-bajaj-finance-to-reissue-over-2-year-bonds-bankers-say/
[3] https://www.etnownews.com/markets/infosys-dividend-2025-record-date-this-week-check-amount-and-payment-date-article-151720004